Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha
Browsing: Roche
Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha
AstraZeneca, Roche cut at Deutsche after trial readouts for key drugs Source: Seekingalpha
Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha
Roche wins FDA nod for Tecentriq version developed with Halozyme Source: Seekingalpha
AstraZeneca, Roche cut at Deutsche after trial readouts for key drugs Source: Seekingalpha
Rafael_Wiedenmeier/iStock Unreleased by way of Getty Images The U.S. FDA has accredited Roche’s (OTCQX:RHHBY) Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) as a twice a yr subcutaneous injection…
Roche wins FDA nod for Tecentriq version developed with Halozyme Source: Seekingalpha
Roche falls while Novo, Lilly gain on weight-loss drug report Source: Seekingalpha
Roche and Singapore’s Qritive collaborate for global cancer diagnostics with AI Source: Seekingalpha